DESCRIPTION
GHK-Cu/BPC-157/TB-500 is a three-component research peptide formulation supplied exclusively for controlled laboratory research environments. This lyophilized blend is intended for non-clinical applications involving peptide characterization, analytical method development, and evaluation of multi-peptide formulations in model systems.
COMPOSITION
• GHK-Cu: 50 mg
• BPC-157: 10 mg
• TB-500 (Thymosin Beta-4): 10 mg
• Appearance: Lyophilized powder in a sealed research vial
RESEARCH FOCUS (NON-CLINICAL)
• Combined evaluation of copper peptide, BPC-157, and TB-500 in laboratory model systems
• Analytical assay development and validation for multi-peptide formulations
• Chromatographic method optimization for separation and impurity profiling
• Stability characterization of multi-component lyophilized peptide blends under laboratory storage conditions
• Identity and purity assessment using validated analytical methods
DOCUMENTATION
• Lot-specific Certificate of Analysis (COA)
• Batch and lot traceability
• QR code access to product documentation
• Manufacturing quality documentation
IMPORTANT NOTICE
• For research use only
• Not for human consumption
• Not intended for diagnostic, therapeutic, veterinary, or clinical use
• Not intended to diagnose, treat, cure, or prevent any disease
QUALITY & MANUFACTURING
• Manufactured in the USA in an ISO 9001-based, cGMP-aligned facility
• Third-party tested with lot-specific Certificate of Analysis (COA)
• Lyophilized for laboratory stability and secure transit
• Tamper-evident seal with printed lot number and test date
• Each lot documented throughout production
